First Page | Document Content | |
---|---|---|
Date: 2014-08-23 01:19:30Health Microbiology Vaccination Vaccines Anthrax vaccines Biodefense Public Readiness and Emergency Preparedness Act H5N1 clinical trials Biology Anthrax Biological warfare | National Biodefense Science Board Letter Re: Stockpiled Anthrax Vaccine Adsorbed (AVA) to Provide Post-Exposure Prophylaxis (PEP) for At-Risk Populations Following an Anthrax AttackAdd to Reading ListSource URL: www.phe.govDownload Document from Source WebsiteFile Size: 24,55 KBShare Document on Facebook |
Microsoft Word - WEBSITE PHASE I RESULT-BARCELONA.docDocID: 1q51G - View Document | |
Microsoft Word - WEBSITE ABL NIAID HBI collaboration.docDocID: 1q4Aa - View Document | |
Microsoft Word - EDUFLUVAC_PR_KoM_final_long_131120DocID: 1njHg - View Document | |
© 2006 Nature Publishing Group http://www.nature.com/naturemedicine BOOK REVIEW A successful vaccine that missed its targetDocID: 1g1wb - View Document | |
Clinical trials charts_091014DocID: 1g0qO - View Document |